Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104

Showing 51-75 of 104 citing articles:

Esophageal squamous cell carcinoma derived sEV-PDL1 exhausts CD8+T cells to promote immunosuppression
Zijie Li, Xiaokuan Zhang, Yuying Qi, et al.
Molecular Immunology (2025) Vol. 178, pp. 12-19
Closed Access
Unravelling the role of ubiquitin-specific proteases in breast carcinoma: insights into tumour progression and immune microenvironment modulation
Huiyuan Yang, Tingting Sun, Zhenni Sun, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Contribution of Macrophages and T Cells in Skeletal Metastasis
Veronica Mendoza‐Reinoso, Laurie K. McCauley, Pierrick G.J. Fournier
Cancers (2020) Vol. 12, Iss. 4, pp. 1014-1014
Open Access | Times Cited: 26
Targeting macrophage priming by polyphyllin VII triggers anti-tumor immunity via STING-governed cytotoxic T-cell infiltration in lung cancer
Jing-Lu Yu, Haibin Deng, Zhenye Xu
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 26
Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature
Tsubasa Watanabe, Elke Firat, Jutta Scholber, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 9, pp. 1823-1832
Open Access | Times Cited: 24
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Molecular Therapy — Oncolytics (2023) Vol. 31, pp. 100733-100733
Open Access | Times Cited: 9
The roles of PD-L1 in the various stages of tumor metastasis
Yinjun He, Ming Zhu, Xuan Lai, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1475-1488
Closed Access | Times Cited: 3
Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples
Yinying Zou, Liming Xu, Qiusu Tang, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort
Taishi Takahara, Akira Satou, Eri Ishikawa, et al.
Virchows Archiv (2020) Vol. 478, Iss. 3, pp. 541-552
Closed Access | Times Cited: 20
PD-L1 antibody enhanced β-glucan antitumor effects via blockade of the immune checkpoints in a melanoma model
Xin Hu, Yifang Shui, Hiroshi Hirano, et al.
Cancer Immunology Immunotherapy (2022) Vol. 72, Iss. 3, pp. 719-731
Closed Access | Times Cited: 12
Extracellular Vesicles Are Important Mediators That Regulate Tumor Lymph Node Metastasis via the Immune System
Yoshitaka Kiya, Yusuke Yoshioka, Yuichi Nagakawa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1362-1362
Open Access | Times Cited: 7
Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer
Chao-Yang Lai, Da‐Wei Yeh, Chih-Hao Lu, et al.
Cancers (2020) Vol. 12, Iss. 1, pp. 148-148
Open Access | Times Cited: 18
The diverse pancreatic tumor cell-intrinsic response to IFNγ is determined by epigenetic heterogeneity
Yueyue Chen, Xuqing Shen, Yingying Tang, et al.
Cancer Letters (2023) Vol. 562, pp. 216153-216153
Closed Access | Times Cited: 6
Sex-dependent PD-L1/sPD-L1 trafficking in human endothelial cells in response to inflammatory cytokines and VEGF
Chiara Baggio, Giovanni Eugenio Ramaschi, Francesca Oliviero, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114670-114670
Open Access | Times Cited: 6
The Sarcoma Immune Landscape: Emerging Challenges, Prognostic Significance and Prospective Impact for Immunotherapy Approaches
Anna Koumarianou, José Durán
Cancers (2021) Vol. 13, Iss. 3, pp. 363-363
Open Access | Times Cited: 13
ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Aditi Mulgaonkar, Roy Elias, Layton Woolford, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 22, pp. 4907-4916
Open Access | Times Cited: 10
Divergent immune landscapes of primary and syngeneic Kras-driven mouse tumor models
Wade R. Gutierrez, Amanda Scherer, Gavin R. McGivney, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors
Wei Yuan, Christos Xiao, Xiang‐Ming Lao, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 867-887
Open Access | Times Cited: 12
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway
Gui‐Lin Jin, Mi Ma, Chunyan Yang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 24, pp. 2493-2503
Open Access | Times Cited: 4
Second-line treatment strategy for urothelial cancer patients who progress or are unfit for cisplatin therapy: a network meta-analysis
Huitao Wang, Jianhe Liu, Kewei Fang, et al.
BMC Urology (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 11
Targeting inflammatory macrophages rebuilds therapeutic efficacy of DOT1L inhibition in hepatocellular carcinoma
Yibin Yang, Cai-Yuan Wu, Xuyan Wang, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 105-118
Open Access | Times Cited: 7
miRNome targeting NF-κB signaling orchestrates macrophage-triggered cancer metastasis and recurrence
Dong‐Ping Chen, Juncheng Wang, Zhengyu Liu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 4, pp. 1110-1124
Closed Access | Times Cited: 1
Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer
Ruibin Wang, Yanjie Zhao
Cancer Management and Research (2024) Vol. Volume 16, pp. 259-268
Open Access | Times Cited: 1
Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma‐associated oncogene homolog 1 and chemokine CCL2
Yiming Luo, Zhi Li, He Zhu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 1
Caspase-4 promotes metastasis and interferon-γ-induced pyroptosis in lung adenocarcinoma
Yosuke Chiba, Tomomitsu Doi, Kunie Obayashi, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 1

Scroll to top